Intellectual Property India Publishes Patent Application for '3-Fluoro-4-Hydroxybenzmide-Containing Inhibitors And/Or Degraders And Uses Thereof' Filed by Pfizer Inc.

MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517055612 A) filed by Pfizer Inc., New York, on June 9, for '3-fluoro-4-hydroxybenzmide-containing inhibitors and/or degraders and uses thereof.'

Inventor(s) include Adams, Jan Antoinette Cusi Romero; Ashkenazi, Yotam; Brown, Matthew Frank; Dutra, Jason Kenneth; Garnsey, Michelle Renee; Hou, Xinjun; Lee, Jisun; Lian, Yajing; Nason II, Deane Milford; O'Neil, Steven Victor; Pecora, Amanda Brooke; Richardson, Alistair Dean; Sammons, Matthew Forrest; Wang, Yang; Wright, Ann Sorrentino; Xiao, Jun; Zhang, Lei; Zhang, Liying; and Edmonds, David James.

The application for the patent was published on July 4, under issue no. 27/2025.

According to the abstract released by the Intellectual Property India: "Described herein are 3-fluoro-4-hydroxybenzamide-containing inhibitors and/or degraders, and pharmaceutical compositions containing 3-fluoro-hydroxybenzamide-containing inhibitors and/or degraders. In some embodiments, the 3-fluoro-4-hydroxybenzamide- containing compounds of the disclosure can be used to treat a condition, for example, nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Formula (II)."

The patent application was internationally filed on Dec. 14, 2023, under International application No.PCT/IB2023/062684.

Disclaimer: Curated by HT Syndication.